MDA-MB-453, an apocrine breast cancer cell line (ER−, PR−, HER2−, AR+) was used as a positive control and SKBR3 (ER−, PR−, HER2+, AR-low) as a negative control. Here, ERBB2 is linked to breast carcinoma.